Analysts remained overwhelmingly bullish on Palantir, although the company’s lofty valuation stood out as a sore spot for some.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The Dow Industrials climbed more than 500 points Monday, as traders managed to look past declines in gold, silver and bitcoin.
Investor Joe Terranova likes Merck despite pharmaceutical firm’s move to lower drug price
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has impacted its business.
The AI trend can give dividend aristocrats a boost, Raymond James says
After years of underperformance, the tide could be starting to shift for dividend stocks, according to Raymond James.
Boring but beautiful — This real estate stock reporting Monday has room to run, says Jay Woods
Investor and trader Jay Woods said there’s a good trading set-up in shopping mall owner Simon Property Group this week.
This chemical stock has the potential for a big turnaround higher, says Katie Stockton
Katie Stockton takes a look at the materials sector, including one stock that could break out soon.
Two ways for U.S. investors to cash in on the weak dollar
A softening U.S. greenback could mean it’s time for investors to look abroad for opportunities, according to Oppenheimer.
These names on Josh Brown’s best stocks list showed strength during last week’s volatility. One is forming a ‘golden cross’
Josh Brown and Sean Russo take a look at the stocks that were strong despite last week’s wild swings.
The risk-reward on this payments stock looks attractive. How to trade it using a risk reversal options trade
Options trader Michael Khouw breaks down this call spread risk reversal on this payments name.
William Blair upgrades Palantir ahead of Monday earnings report, sees shares rising back to $200
William Blair’s $200 price target implies that shares of Palantir could surge 36% from current levels.